CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...